Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
2002 1
2003 3
2004 8
2005 11
2006 5
2007 9
2008 14
2009 13
2010 11
2011 15
2012 30
2013 36
2014 37
2015 41
2016 29
2017 26
2018 26
2019 29
2020 32
2021 22
2022 14
2023 11
2024 9
2025 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

407 results

Results by year

Filters applied: . Clear all
Page 1
Safety and immunogenicity of a phase 1/2 randomized clinical trial of a quadrivalent, mRNA-based seasonal influenza vaccine (mRNA-1010) in healthy adults: interim analysis.
Lee IT, Nachbagauer R, Ensz D, Schwartz H, Carmona L, Schaefers K, Avanesov A, Stadlbauer D, Henry C, Chen R, Huang W, Schrempp DR, Ananworanich J, Paris R. Lee IT, et al. Nat Commun. 2023 Jun 19;14(1):3631. doi: 10.1038/s41467-023-39376-7. Nat Commun. 2023. PMID: 37336877 Free PMC article. Clinical Trial.
What Will It Take to Cure HIV?
Ananworanich J. Ananworanich J. Top Antivir Med. 2015 May-Jun;23(2):80-4. Top Antivir Med. 2015. PMID: 26200707 Free PMC article. Review.
This article summarizes a presentation by Jintanat Ananworanich, MD, PhD, at the IAS-USA continuing education program held in New York, New York, in October 2014....
This article summarizes a presentation by Jintanat Ananworanich, MD, PhD, at the IAS-USA continuing education program held in New Yor …
Safety and Immunogenicity of mRNA-1010, an Investigational Seasonal Influenza Vaccine, in Healthy Adults: Final Results From a Phase 1/2 Randomized Trial.
Ananworanich J, Lee IT, Ensz D, Carmona L, Schaefers K, Avanesov A, Stadlbauer D, Choi A, Pucci A, McGrath S, Kuo HH, Henry C, Chen R, Huang W, Nachbagauer R, Paris R. Ananworanich J, et al. J Infect Dis. 2025 Feb 4;231(1):e113-e122. doi: 10.1093/infdis/jiae329. J Infect Dis. 2025. PMID: 38934845 Free PMC article. Clinical Trial.
Immunogenicity and Safety of Influenza and COVID-19 Multicomponent Vaccine in Adults ≥50 Years: A Randomized Clinical Trial.
Rudman Spergel AK, Wu I, Deng W, Cardona J, Johnson K, Espinosa-Fernandez I, Sinkiewicz M, Urdaneta V, Carmona L, Schaefers K, Girard B, Paila YD, Mehta D, Callendret B, Kostanyan L, Ananworanich J, Miller J, Das R, Shaw CA. Rudman Spergel AK, et al. JAMA. 2025 Jun 10;333(22):1977-1987. doi: 10.1001/jama.2025.5646. JAMA. 2025. PMID: 40332892 Clinical Trial.
A cure for HIV: what will it take?
Ananworanich J, Mellors JW. Ananworanich J, et al. Curr Opin HIV AIDS. 2015 Jan;10(1):1-3. doi: 10.1097/COH.0000000000000125. Curr Opin HIV AIDS. 2015. PMID: 25389807 No abstract available.
HIV rapidly targets a diverse pool of CD4+ T cells to establish productive and latent infections.
Gantner P, Buranapraditkun S, Pagliuzza A, Dufour C, Pardons M, Mitchell JL, Kroon E, Sacdalan C, Tulmethakaan N, Pinyakorn S, Robb ML, Phanuphak N, Ananworanich J, Hsu D, Vasan S, Trautmann L, Fromentin R, Chomont N. Gantner P, et al. Immunity. 2023 Mar 14;56(3):653-668.e5. doi: 10.1016/j.immuni.2023.01.030. Epub 2023 Feb 17. Immunity. 2023. PMID: 36804957 Free PMC article.
Lessons from acute HIV infection.
Robb ML, Ananworanich J. Robb ML, et al. Curr Opin HIV AIDS. 2016 Nov;11(6):555-560. doi: 10.1097/COH.0000000000000316. Curr Opin HIV AIDS. 2016. PMID: 27716734 Free PMC article. Review.
407 results

Searches related to "ananworanich"